Evidence map›Paper›PMID 29362233›Full record

ArticlemBio2018

Genomic Analyses Reveal the Common Occurrence and Complexity of

Jean Popovici, Lindsey R Friedrich, Saorin Kim, Sophalai Bin, Vorleak Run, Dysoley Lek, Matthew V Cannon, Didier Menard, David Serre

Abstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Population heterogeneity in Plasmodium vivax relapse risk.PLoS neglected tropical diseases · 2022
    Trial
  3. Trial
  4. Article
  5. UnderstandingiScience · 2026
    Article
  6. Frequent and genetically diverseResearch square · 2026
    Article
  7. Observational
  8. Article
  9. Article
  10. Recurrent Malaria withTropical medicine and infectious disease · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Single-cell analyses of polyclonalResearch square · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean PopoviciMalaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.
Lindsey R FriedrichGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Saorin KimMalaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.
Sophalai BinMalaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.
Vorleak RunMalaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.
Dysoley LekNational Center for Malaria Control, Phnom Penh, Cambodia.
Matthew V CannonGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-3035-9490
Didier MenardMalaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia dmenard@pasteur.fr dserre@som.umaryland.edu.
David SerreGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA dmenard@pasteur.fr dserre@som.umaryland.edu.

Funding

Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in CambodiaR01AI103228 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SERRE, DAVID · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI103228
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic VariationGenotypeCambodiaFemaleGenotyping TechniquesHumansMalaria, VivaxMalePlasmodium vivaxRecurrenceWhole Genome SequencinggenomicsmalariaPlasmodium vivaxrelapse

Identifiers

PMID29362233
PMCPMC5784252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.